SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
154.40    1.60 (1.05%)
Bid:
154.40
Ask:
154.80
Spread: 0.40 (0.259%)
Market Cap: £883.65m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Trading Update

21 Jan 2025 07:00

RNS Number : 0269U
Elementis PLC
21 January 2025
 

 

21 January 2025

 

 

 

Elementis plc

Trading Update

 

Results ahead of expectations, continued strategic progress.

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues its scheduled trading update for the three months and year ended 31 December 2024.

 

Elementis will publish its results for the financial year to 31 December 2024 on 6th March 2025.

 

A strong performance, ahead of expectations

The Group has delivered a strong fourth quarter performance, with continued revenue growth and double-digit profit growth across Coatings and Personal Care, compared with Q4 2023.

 

As a result, adjusted operating profit for the financial year 2024 is expected to be in the range of $126-128 million, ahead of expectations1, and significantly higher compared with the prior year (2023: $104 million).

 

Adjusted operating margin above 17% for the 2024 financial year (2023: 14.6%) demonstrates good progress on the efficiency and growth programmes, introduced at the November 2023 Capital Markets Day.

 

Cash generation strengthens balance sheet

Strong cash generation supported further deleveraging, with net debt anticipated to be below $160 million (pre IFRS 16) at the end of the financial year 2024 (2023: $202 million). This represents a leverage ratio of approximately 1.0x net debt to EBITDA (pre IFRS 16), down from 1.5x at the start of the year.

 

Talc strategic review

The strategic review of Talc, announced on 1st August, is progressing and a further update will be provided in due course.

 

 

Note: 1. Based on company compiled consensus: FY 2024 adjusted operating profit range of $121-125 million.

 

Enquiries

Investors: Eva Hatfield, Elementis plc Tel: +44 7553 340380

Press: Olivia Peters/Martin Robinson, Teneo Tel: +44 (0) 20 7353 4200

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAXFEASPSEFA
Date   Source Headline
29th Nov 201311:00 amRNSTotal Voting Rights
31st Oct 201311:00 amRNSTotal Voting Rights
25th Oct 20137:00 amRNSInterim Management Statement
16th Oct 20131:00 pmRNSAdditional Listing
1st Oct 20139:00 amRNSDirectorate Change
30th Sep 201311:00 amRNSTotal Voting Rights
6th Sep 20131:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20134:00 pmRNSBlocklisting Interim Review
30th Aug 20131:00 pmRNSTotal Voting Rights
28th Aug 201311:00 amRNSDirector/PDMR Shareholding
23rd Aug 20134:30 pmRNSHolding(s) in Company
2nd Aug 20134:00 pmRNSHolding(s) in Company
31st Jul 20134:01 pmRNSHolding(s) in Company
31st Jul 20134:00 pmRNSDirector/PDMR Shareholding
31st Jul 20131:00 pmRNSTotal Voting Rights
30th Jul 20137:00 amRNSInterim Results
22nd Jul 20137:00 amRNSDirectorate Change
3rd Jul 201311:00 amRNSHolding(s) in Company
28th Jun 201312:42 pmRNSTotal Voting Rights
3rd Jun 201312:00 pmRNSTotal Voting Rights
22nd May 201311:00 amRNSAdditional Listing
7th May 20131:00 pmRNSDirector/PDMR Shareholding
7th May 20137:00 amRNSDirectorate Change
30th Apr 201311:00 amRNSTotal Voting Rights
25th Apr 20133:12 pmRNSResult of AGM
25th Apr 20137:00 amRNSAGM Statement
12th Apr 201311:00 amRNSDirector/PDMR Shareholding
3rd Apr 20134:10 pmRNSDirector/PDMR Shareholding
28th Mar 201311:30 amRNSTotal Voting Rights
25th Mar 201311:00 amRNSHolding(s) in Company
21st Mar 20139:30 amRNS2012 Annual Financial Report & Notice of 2013 AGM
6th Mar 201311:00 amRNSAdditional Listing
6th Mar 201311:00 amRNSHolding(s) in Company
6th Mar 201311:00 amRNSHolding(s) in Company
1st Mar 201311:00 amRNSBlocklisting Interim Review
28th Feb 201311:00 amRNSTotal Voting Rights
26th Feb 20137:00 amRNSFinal Results
25th Feb 201311:00 amRNSHolding(s) in Company
20th Feb 20137:00 amRNSAcquisition
8th Feb 201311:00 amRNSDirector Declaration
1st Feb 201311:00 amRNSDirector/PDMR Shareholding
31st Jan 201311:00 amRNSTotal Voting Rights
24th Jan 201311:00 amRNSHolding(s) in Company
24th Jan 201311:00 amRNSHolding(s) in Company
17th Jan 201311:00 amRNSDirector/PDMR Shareholding
2nd Jan 201311:00 amRNSTotal Voting Rights
30th Nov 201211:00 amRNSTotal Voting Rights
7th Nov 201211:00 amRNSAdditional Listing
31st Oct 20121:00 pmRNSTotal Voting Rights
26th Oct 20127:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.